Widespread, risky use clotting drug on non-hemophilia patients documented in new studies

An expensive blood-clotting drug that is intended only for hemophilia patients is being used in hospitals predominantly to treat patients without this disorder, despite evidence suggesting that it could harm them, according to a pair of studies.